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ABSTRACT 
Background: Tuberculous meningitis (TBM) is one of the most devastating complications of 
tuberculosis (TB)3 and contributes significantly to the morbidity and mortality of children in 
high burden TB countries.2 Early diagnosis of TBM is notoriously difficult due to its 
inconsistent clinical presentation and lack of a rapid, sensitive and specific diagnostic test. 
Decision-making in resource-constrained countries is most often guided by use of simple 
cerebrospinal fluid (CSF) analysis. However, the classical CSF findings of lymphocyte 
predominance, low glucose and high protein,
5,7,16-20 are only simultaneously present in one third 
of cases5, whilst bacteriological confirmation only occurs in 15-40% of cases.17,18,21,23 
Neutrophil predominance,22,24,26 high protein concentrations and Human Immunodeficiency 
virus (HIV) infection24 is thought to increase likelihood of microbiological culture.  
Defining the CSF parameters that are associated with confirmation of Mycobacterium 
Tuberculosis will allow for an increased suspicion, and hopefully earlier diagnosis and 
treatment; especially if those parameters identified are associated with a traditionally atypical 
TBM CSF picture, higher bacillary load and is influenced by HIV status. 
Aim: To describe the CSF parameters that affect the sensitivity of bacteriological confirmation 
of TBM in 491 CSF samples of children diagnosed with the disease in the past 30 years, at 
Tygerberg Children’s Hospital (TCH) in the Western Cape Province of South Africa. 
Methods: Retrospective analysis of 491 cases, meeting the diagnostic criteria of definite and 
probable TBM.  
Conclusion: 46% of TBM cases do not display the characteristic CSF profile traditionally 
associated with TBM. Clinico-diagnostic features including neutrophil predominance is not 
predictive of bacteriological confirmation. However neutrophil predominance was associated 
with earlier disease manifestations.  





Agtergrond: Tuberkuleuse breinvliesontsteking is een van die mees verwoestende 
komplikasies van tuberkulose, en dra betekenisvol tot die morbiditeit en mortaliteit van kinders 
in hoë TB-belaste nasies by.2 Die vroeë diagnose van tuberkuleuse breinvliesontsteking is 
berug daarvoor om moeilik te wees, dit is grootendeels as gevolg van die onkonsekwente 
manier waarop dit klinies voordoen, asook die gebrek aan ‘n spoedige, sensitiewe en spesifieke 
diagnostiese toets. Besluitneming in lande met beperkte hulpbronne word meestal  gelei deur 
die gebruik van eenvoudige serebrospinale vog (SSV) ontleding. 
Die klassieke SSV bevindinge van oorheersende limfosiete, lae glukose en ‘n hoë proteïen5,7,16-
20is egter net gelyktydig teenwoordig in ‘n derde van gevalle,5 en tuberkuleuse 
breinvliesontsteking word bakterieël bevesting in slegs sowat 15-40% van 
gevalle.17,18,21,23Oorheersende neutrofiele,22,24,26  hoë proteïen konsentrasies en HIV 
positiwiteit24 is geidentifiseer as faktore wat die waarskynlikheid van mikrobiologiese kweking 
kan verhoog. 
Deur die SSV parameters te identifiseer wat geassosieer word met bevestigte Mycobacterium 
Tuberculosis infeksie, sal dit toelaat vir verhoogde suspisie, en hopelik vroeër diagnose an 
behandeling; veral as daardie geidentifiseerde parameters geassosieer word met ‘n tradisioneel 
atipiese tuberkuleuse breinvliesontsteking SSV beeld, hoër basillêre lading en deur HIV 
beïnvloed word. 
Doelstelling: Om die SSV parameters te beskryf wat die sensitiwiteit van bakteriologiese 
bevestiging van tuberkuleuse breinvliesontsteking affekteer, in 491 SSV monsters van kinders 
wat met diè siekte gediagnoseer is in die afgelope 30 jaar, by die Tygerbergse Kinder Hospitaal 
in die Wes-Kaap Provinsie van Suid Afrika. 
Metodes: Retrospektiewe ontleding van 491 gevalle wat aan die diagnostiese kriteria voldoen 
vir definitiewe en waarskynlike tuberkuleuse breinvliesontsteking. 
Resultate: 46% van die tuberkuluese breinvliesontsteking gevalle vertoon nie die klassieke 
SSV bevindinge wat tradisioneel daarmee geassosieer word nie. Kliniese en diagnostiese 
voordoening, insluitend ‘n beeld van oorheersende neutrofiele op SSV is nie aanduidend van 
‘n verhoogde kans op mikrobiologiese bevestiging nie. Oorheersende neutrofiele is egter 
gessosieer met vroeë siekte. 
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INTRODUCTION AND LITERATURE REVIEW 
  
 
The first literary reference to tuberculous meningitis (TBM) was made in the Lancet of 18361. 
Then termed “acute hydrocephalus”, the disease was uniformly fatal, and diagnosis could only 
be confirmed by post mortem examination. 
175 years later, the burden of the disease has significantly increased, with an estimated 9 
million new tuberculosis (TB) cases diagnosed globally in 2013, of which 550 000 occurred in 
children2. Although the 2015 Millennium Development Goal of halting and reversing TB 
incidence has been achieved globally, an estimated 1.5million people still died from this 
preventable and treatable disease in 2013. 
TBM is one of the most devastating complications of TB3, and continues to contribute 
significantly to the morbidity and mortality of the paediatric population, especially in such a 
high burden TB country as South Africa. 4 
One of the most important determinants of the outcome of TBM is the early and rapid diagnosis 
of the disease. 5-7 However, diagnosis is especially difficult in children, due to the 
paucibacillary nature of disease and suboptimal diagnostic testing. 8-11 As a result, decision 
making is often guided by history, clinical presentation, as well as the cerebrospinal fluid (CSF) 
findings.  
 
CSF findings in childhood TBM 
CSF features highly suggestive of TBM in TB endemic areas include:12-15 
 
A. Moderately increased leukocytosis (10-500 cells/μL with >50% lymphocyte 
predominance. 5,7,16-20 
B. Elevated protein (>1g/L) 5,16-20 
C. An abnormally decreased CSF to serum glucose ratio <0.5 or an absolute CSF glucose 
concentration less than 2.2 mmol/L. 5, 16-21  
Although these classically described findings may be characteristic of TBM, various 
studies5,16,18,21-27 have shown that it lacks specificity as a diagnostic tool.  
In a 2004 study by van den Bos et al16, the CSF of 104 children with TBM were analysed, 
polymorphonuclear leucocytes were predominant in the CSF of 17%; in 16% the CSF glucose 
was >2.2mmol/l; and in 26% the CSF protein was <0.8g/l. Similarly, in a Turkish study of 214 
children18, diagnosed with TBM on clinical and microbiological criteria, 15% had a 
polymorphonuclear predominance; 17% had a CSF glucose of >2.2mmol/l; and 23% a CSF 
protein lower than 1g/dl. 
VB Patel in their 2008 South African study5, found the characteristic CSF findings in only 34% 
of their 99 patients with TBM. This correlates with another South African study21 by PR 
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Donald et al, that found a polymorphonuclear predominance in 9%, a CSF glucose of 
>2.2mmol/l in 40% and a CSF protein of <0.8g/l in 18% of their 99 children with TBM. 
 
Therefore, the characteristic CSF parameters used in most case definitions for TBM, may miss 
up to two thirds of children with the disease, adding to the disease morbidity and mortality, 
given the poor outcome with delayed initiation of anti-tuberculous therapy.  
 
Bacteriological confirmation 
The bacteriological confirmation of Mycobacterium tuberculosis (M.tuberculosis) by 
identification of acid fast bacilli on CSF microscopy, positive CSF M.tuberculosis culture and 
positive commercial nucleic-acid amplification test (NAAT) confirms the diagnosis of TBM. 
16,22,28 Many studies use microbiological evidence as the reference standard when analysing 
CSF parameters in patients with TBM.16,22 Yet, research has shown that most TBM cases will 
not be proven microbiologically. Less than half of patients who satisfied clinical diagnostic 
criteria for TBM, had a positive CSF culture of the organism. Therefore, using CSF culture 
positivity as a diagnostic criteria will fail to identify more than half of all TBM cases.17,18,21,29 
 
Likelihood of TBM bacteriological confirmation 
Certain CSF parameters increase the likelihood of bacteriological confirmation of 
M.tuberculosis. It is proposed that CSF neutrophil predominance is associated with the 
discharge of a large amount of tuberculoprotein into the CSF, typically occurring in the initial 
and acute phase of the infection. Therefore, a polymorphonuclear pleocytosis increases the 
likelihood of a positive culture for M.tuberculosis. 22,26,30 Elevated CSF protein concentration, 
as well as co-infection with the human immunodeficiency virus (HIV), have been associated 
with increased detection of M.tuberculosis on CSF culture.30  
 
Defining parameters that are associated with confirmation of M.tuberculosis will allow for an 
increased suspicion, and hopefully earlier diagnosis and treatment; especially if those 
parameters identified are associated with a better outcome. 
 
  






1.  AIMS AND OBJECTIVES: 
 
 
a. Research question:  
 
Null hypothesis: There is no difference in the clinical presentation, radiological imaging and 




The primary aim of this study is to determine whether there is a difference in the clinical 
presentation, radiological imaging and CSF findings of children diagnosed with probable and 
definite TBM over the past 30 years at Tygerberg Children’s Hospital (TCH). 
The secondary aim is to identify cases of definite and probable TBM with a neutrophil 
predominance in the CSF, and determine whether it is associated with bacteriological 





Probable and definite TBM cases will be analysed to determine the difference in: 
a. Demographics and baseline characteristics  
b. Clinical disease characteristcs at presentation 
c. Results of radiological, laboratory and cerebrospinal fluid investigations 
Secondly, probable and definite TBM cases with neutrophil predominance will be analysed, to 
determine the association with: 
a. Bacteriological confirmation 
b. Severity of TBM disease 
c. Clinical presentation 
d. Radiological changes 
 
2. STUDY DESIGN  
  
 
A retrospective, observational study, using a cross-sectional design, comparing the CSF 
samples of paediatric patients with definite and probable TBM. The independent variable is 
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bacteriological confirmation of M. tuberculosis on CSF (definite TBM), versus probable TBM 
(inability to demonstrate M. tuberculosis from CSF. The dependent variable will be the 
demographic, clinical, and diagnostic parameters assessed. 
 
3. METHODS  
 
 
The study was conducted at Tygerberg Children’s Hospital (TCH), a tertiary level referral 
hospital in Cape Town, South Africa, serving a population of over 2.6 million people in the 
Western Cape Province. The hospital’s drainage area includes the Northern Metro subdistricts, 
Khayelitsha, Eastern Tygerberg, West Coast, Cape Winelands and Overberg rural districts. The 
hospital has 1899 beds, of which 319 are allocated to paediatrics. 
 
The Western Cape province of South Africa is a region where TB occurs endemically and is 
considered a high burden TB region. In 2005 children aged less than 13 years comprised 13.7% 
of the total disease burden, and had a reported incidence of 400/100 000 per year.31  
 
A patient presenting to health care services with features suggestive of TBM, would be referred 
from primary health care clinics and hospitals to secondary and/ or tertiary hospitals, as the 
diagnosis becomes evident. Upon arrival to TCH, the patient and available results (usually a 
basic screening test  for TB (Mantoux/ PPD), basic radiography like a chest X-ray, 
cerebrospinal fluid cell counts and chemistry if a lumbar puncture was not contraindicated, and 
basic serological results including a full blood count, C-reactive protein and human 
immunodeficiency virus (HIV) test) would be evaluated. If warranted, further tests would 
include a computerised tomography (CT) scan of the brain, an airencephalogram, and further 
serological and cerebrospinal fluid tests. A patient would then be classified as possible, 
probable or definite TBM, according to the uniform case definition (see Appendix 1). The 
severity would be staged according to the British Medical Research Council (BMRC) staging 
system (see below). Treatment is initiated as soon as the diagnosis is suspected, and not delayed 
until confirmatory test results are available. Once a decision has been made to continue 
treatment, a course of anti-tuberculous chemotherapy, with adjunctive corticosteroids, is given 
for 6 months: Rifampicin 20mg/kg, Isoniazid 20mg/kg, Pyrazinamide 40mg/kg and 
Ethionamide 20mg/kg. Prednisone 4mg/kg weaned over 4 weeks after a month on treatment. 
Appropriate referrals are made to neurosurgery, physiotherapy, occupational therapy and social 
services. Care during and after treatment can be continued at our institution, one of the TB 
hospitals in the province or supervised by specialised home-based care programmes. 
 
A database containing information about all suspected, possible, probable and definite TBM 
cases, occurring in children aged 3 months to 13 years, between the 1st January 1985 and 31st 
December 2015 was utilized to extract relevant data from. This database has been utilized in 
previous TBM studies. (HREC reference numbers N10/11/367, N11/01/006)38,39 
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The data from children admitted with suspected, possible, probable and definite TBM were 
transcribed onto a case recording form, allocated a study number and then added to the 
anonymised database.  
 
The case definition20 was utilized to identify probable and definite cases of TBM from the 
database. Samples from the above group with neutrophil predominance were also selected for 
further analysis. 
 
Inclusion criteria that was utilised were definite and probable TBM cases, presenting for 
diagnosis of TBM or initiation or continuation of TBM treatment with a documented 
cerebrospinal fluid (CSF) lymphocyte and neutrophil count. 
 
Samples were excluded if they did not satisfy the diagnostic and clinical criteria for probable 
and definite TBM (i.e. suspected and possible TBM), and if caregivers did not give permission 
to participate in the research project. 
 
4. DEFINITIONS  
 
a. Tuberculous meningitis (TBM) case definitions: 
The uniform research case definition for TBM20 was used to classify patients as definite or 
probable TBM. (Appendix 1) 
 
Definite TBM 
A diagnosis of ‘definite’ TBM was made if acid-fast bacilli were present in the CSF, 
M.tuberculosis was cultured from CSF, a commercial nucleic acid amplification test of CSF 
was positive or there was histopathological evidence of M.tuberculosis from a central nervous 
system site.  
 
Probable TBM 
The diagnosis was made if two or more of the following criteria were present in the setting of 
a characteristic history and CSF changes associated with TBM: a positive history of contact 
with an adult TB case, a positive tuberculin skin test, a chest x-ray suggestive of pulmonary 
tuberculosis (hilar lymphadenopathy, miliary tuberculosis or cavitation), CT or magnetic 
resonance imaging (MRI) demonstrating the characteristic features of TBM (ventricular 
dilatation, meningovascular enhancement and/or granuloma/s), poor weight gain/ weight 
crossing percentiles documented on the Road to Health Card or positive microbiological 
identification of acid fast bacilli from gastric washings. 
 
b. Severity of TBM at diagnosis was classified according to: 
The refined British Medical Research Council (BMRC) staging system17 as: 
Stage I: Glasgow Coma Scale (GCS) of 15 and no focal neurology;  
Stage IIa: GCS of 15 plus focal neurology;  
Stage IIb: GCS of 11-14 with focal neurology;  
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Stage III: GCS <11. 
 
c. Meningeal irritation 
Meningeal irritation was considered to be present when nuchal rigidity, a positive Kernig or 
positive Brudzinski sign was demonstrable. 
 
d. Brain stem dysfunction 
Included all cases presenting with dysfunction of the spinothalamic, posterior column and 
corticospinal tract; as well as cranial nerve III to XII fallout. Clinical features include, but were 
not limited to: pupillary abnormalities, diplopia, weakness, vertigo, dysphagia, dysphonia, 
ataxia, breathing abnormalities, abnormal posture and diminished or absent brainstem reflexes. 
 
e. Hemiparesis 
A hemiparesis was present if muscular weakness or partial paralysis occurred unilaterally.  
 
f. Human immunodeficiency virus (HIV) infection: 
Cases were considered HIV infected if the diagnosis was established using the HIV enzyme-
linked immunosorbent assay (ELISA) in patients older than 18 months, or the HIV polymerase 
chain reaction (PCR) test in those younger than 18 months. An unconfirmed rapid (point of 
care) HIV test was not included in the criteria. 
 
g. Radiological signs of pulmonary Tuberculosis on chest X-ray: 
A chest X-ray was considered suggestive of pulmonary Tuberculosis if it displayed the 
following characteristics: segmental or lobar airspace consolidation with ipsilateral hilar and 
mediastinal lymphadenopathy and/or pleural effusion and/or cavitatory changes. 
Haematogenous dissemination of Tuberculosis, visible as a miliary picture on chest X-ray, was 
also considered suggestive of pulmonary Tuberculosis. 
 
h. Cerebrospinal fluid parameters: 
Four CSF features suggestive of TBM were assessed: 
1. Clear macroscopic appearance 
2. Moderately increased leucocytosis (10-500 cells/μL or >50% lymphocyte predominance.  
3. Elevated protein (>1g/L)  
4. An abnormally decreased CSF to serum glucose ratio or an absolute CSF glucose of 
<2.2mmol/L. 
CSF was considered typical of TBM when all four the above was present. 
 
i. Neutrophil predominance 
CSF samples with more than 50% neutrophils on cell count were considered to be neutrophil 
predominant. 
 
5. STATISTICAL METHODS  
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Statistical analysis was carried out using SPSS version 21 (SPSS Inc, Chicago, IL, USA). 
Numerical variables were summarised using means, standard deviations and ranges, if the data 
was normally distributed. In the case where it was not normally distributed; medians, 
interquartile ranges, minimums and maximums was used. Categorical variables were tabulated 
using proportions and percentages. 
 
For bivariate associations the t-test was used in the case of numerical variables. The Chi-square 
test was used for associations between categorical variables. The measures of associations 
depended on whether or not the data was normally distributed. These included the Pearson 
correlation coefficient, odds ratio, relative risk and the Mann Whitney test. Significance was 
set at the 5% level or p-value of less than 0.05. 
 
6. ETHICAL CONCERNS AND CONSIDERATIONS 
 
The following ethical principles were adhered to during the course of this study: 
a. Social value:  
TBM is a major public health problem, affecting a very vulnerable group of patients, especially 
in a high burden disease country as South Africa. By evaluating the CSF parameters that 
influence bacteriological confirmation, we aimed to relieve the diagnostic burden imposed 
upon health care staff. This translates into earlier diagnosis and initiation of effective treatment 
of this devastating disease. 
 
b. Respect for persons 
Only retrospectively collected data was analysed in this study. There was no direct contact 
between the researcher and patients. 
 
c. Privacy and confidentiality 
All information/data collected was kept in a separate password protected file and this was only 
known to, and accessed by the researchers. There were no risks for parents, patients or medical 
personnel involved in the study.  
 
d. Independent review 
The protocol was approved by the Health Research Ethics Committee (HREC) of Stellenbosch 
University, with ethics approval number S15/07/152. 
 
e. Informed consent 
A waiver of individual informed consent was granted by the HREC as there was no contact 
between the researcher and subjects, data had already been collected retrospectively, there were 
minimal risks to the subjects involved and the study did not adversely affect the right and 
welfare of the subjects. 
 
f. Collaborative partnerships  
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The researchers worked closely with their supervisors, advisors and stakeholders. Ethical 
principles, especially privacy and confidentiality, were strictly adhered to. 
  





A total of 491 cases complied with the inclusion criteria as set out above. Of those, 98 had 
definite TBM, whilst 393 cases satisfied the criteria for probable TBM.  
 
Demographic profile and baseline characteristics 
Table 1 (see Appendix 2) illustrates the demographic differences between the definite and 
probable TBM cases. There was no statistically significant difference in age, gender and 
ethnicity between the two groups.   
 
Clinical presentation 
Table 2 (see Appendix 2) compared the differences in clinical presentation between definite 
and probable TBM cases. There were no statistically significant differences regarding stage of 
disease on presentation. The only presenting symptom that was significantly different was 
vomiting, occurring more in definite TBM cases (p=0.013). Definite TBM cases were also 
more likely to have a BCG scar (p=0.006), whilst probable TBM cases were more likely to 
exhibit meningeal irritation on admission (p<0.001), present with an acute hemiparesis 
(p<0.001) and have a longer duration of illness (p<0.001). 
 
Laboratory, CSF and radiological investigations 
Table 3 (see Appendix 2) illustrates the differences in laboratory, CSF and radiological 
investigations between probable and definite TBM cases. The prevalence of HIV infection was 
low (3%) in both groups. There were no statistically significant differences in CSF 
biochemistry and cell count, with 54% of samples in both groups displaying the typical TBM 
CSF picture. Patients with definite TBM tended to have a higher prevalence of Tuberculin 
reactivity (Mantoux) (p=0.03), whilst children with probable TBM were more likely to exhibit 
chest radiography changes suggestive of PTB (p=0.002). Those in the probable TBM group 
were also more likely to have cerebral infarcts on CT scan (p=0.002), as well as features 
suggestive of hydrocephalus (p=0.033). 
 
Neutrophil predominant samples 
Table 4 (see Appendix 2), shows the differences between neutrophil predominant and 
lymphocyte predominant CSF samples in all the TBM patients. Patients with CSF neutrophil 
predominance were less likely to have advanced TBM disease (p=0.019), but more likely to 
have a miliary picture on chest X-ray (CXR) (0.005). 
  





In this study we compared the differences in clinical presentation, radiological imaging and 
cerebrospinal fluid (CSF) findings of children diagnosed with probable and definite 
tuberculous meningitis (TBM) in a leading tertiary hospital in South Africa.  
 
There were no statistically significant differences in the demographics of the two groups, and 
the ethnic distribution reflects the epidemiology of TB in South Africa. 
 
The majority of patients presented with advanced stage disease. The delay in presentation to 
the referral centre may reflect the broad differential diagnosis for initial presenting symptoms, 
the paucibacillary nature of the disease in childhood and a complex referral pathway from 
primary and district services. Most of the available literature agrees that duration of symptoms 
before admission is an important predictor of TBM diagnosis4,17,18Unexpectedly, culture 
positive cases were more likely to present with less advanced stage disease and have a shorter 
duration of illness. The difficulty in culturing the bacilli especially in the pediatric population, 
due to its paucibacillary nature and the availability of GeneXpert molecular DNA testing from 
2012 onwards, while cases in the study population are included from 1985, are cited as possible 
explanations. 
The clinical presentation of TBM is highly variable and early clinical diagnosis notoriously 
difficult, especially when taking the non-specific signs and symptoms of the early stages into 
account. Vomiting was the only symptom to differ between the two groups, with more culture 
confirmed definite cases presenting with vomiting. TB associated hydrocephalus leads to raised 
intracranial pressure which in turn causes vomiting. It is therefore a manifestation of disease 
progression, and expected to occur more frequently in advanced stage disease.  
The presence of hemiparesis is included in the staging criteria of TBM, and is a strong predictor 
of the prognosis of the disease process. Hemiparesis was present in more of the probable TBM 
cases. Previous studies34,35 conducted on adult patients revealed either no difference, or a 
statistically insignificant difference in the prevalence of hemiparesis among their definite and 
probable cases.  
Meningeal irritation is a reflection of duration of symptoms, severity of the disease stage and 
the immune status of the host. It is a clinical sign not typically present in stage I disease. The 
prevalence of meningism in the study population as a whole was 88%, which is not consistent 
with previous studies17-18, but linked to prolonged duration of symptoms. Previous pediatric 
studies have documented the number of patients diagnosed with TBM who presented with 
nuchal rigidity, but failed to discern between probable and definite cases. Table 5, Appendix 2 
is a summary of adult data differentiating between the clinical presentation of probable and 
definite TBM cases. 
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More patients with definite TBM had a previous BCG scar, in comparison to cases with 
probable TBM. Although the reason for difference between the two groups is unclear, it is 
worrying that almost 40% of the study participants had a scar present. The limited effect of 
BCG vaccination is well known3, but the number is particularly disappointing as studies outside 
of South Africa17,18 reported a much lower immunization rate in their TBM cases. It is however 
a much better figure than the worrying 83% of immunised children with TBM found in a 1995 
study by PR Donald et al, also conducted at Tygerberg Hospital.33 
 
More patients with definite TBM had a positive Mantoux skin test, and 41% of patients overall 
had a positive skin reaction. In both groups patients presented fairly late in the course of their 
illness, so one cannot postulate that they presented too early in their course to have mounted a 
type 4 immune reaction, and neither can improper technique or inter-observer variability be to 
blame for the significant difference in this large sample size. However, disseminated TB, 
malnutrition, HIV and an age less than 6 months can account for false negatives which could 
explain why more than half of patients did not mount an immune reaction. The prevalence of 
HIV in the sample was small, but the cutoff (≥5mm) for a positive Mantoux was adjusted for 
HIV positivity; moreover malnutrition was not assessed and could also have contributed. 
TBM is a paucibacillary disease in children, with diagnosis often guided by simple CSF 
analysis. Studies have shown conflicting results in the number of patients whose initial CSF 
display the classically described findings suggestive of TBM. Data from both adults and 
children,5,18,22,23show typical CSF features in 27-80% of their patients. 
Neutrophil predominance has traditionally been described early in the course of disease, and 
has been associated with an increased likelihood of bacteriological diagnosis.26We therefore 
expected a higher prevalence of neutrophil predominance in our definite TBM group, but found 
that an equal percentage of both groups had more than 50% polymorphonuclear cells in the 
CSF.  
The prevalence of pulmonary changes on CXR was higher in the probable TBM group, and 
can be explained on the basis that the group as a whole had a longer duration of symptoms on 
presentation.  
TBM was first termed “acute hydrocephalus”1, called as such due to the inflammatory exudates 
that accumulate at the base of the brain after the rupture of a caseous granuloma in the 
subarachnoid space. Hydrocephalus is a common complication of TBM, and has been found 
in 42-99% of cases.14,34 Non-communicating or obstructive hydrocephalus makes out about a 
quarter of these.14 Hydrocephalus is a manifestation of stage II and III disease, and its 
prevalence was determined by both air-encephalography and computerised tomography (CT) 
scan of the brain. The majority of cases in both groups had hydrocephalus; and was classified 
as non-communicating in a third of cases. A previous Indian and South African study32,40 also 
revealed a similar prevalence between their two groups. 
Infarctions in TBM are mostly secondary to an on-going vasculitic process and commonly 
affect the basal ganglia. The presence of an infarction on neuroimaging is uniformly associated 
with a poor prognosis. Previous studies have shown a prevalence of 9-56% of infarcts in 
patients with TBM.12,14,29,32,36 Twice as many of our probable cases had an infarct on CT scan, 
most likely linked to the longer duration of illness in that group.  
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It is thought that neutrophil predominance on cerebrospinal fluid is more likely to occur early 
in the disease process and be associated with an increased likelihood of culture positivity.26 
Neutrophil predominant samples were associated with less advanced disease, in comparison to 
lymphocyte predominant samples which were associated with an advanced stage of TBM. 
There was also no statistically significant difference in the number of patients with positive 
CSF cultures between the neutrophil predominant and lymphocyte predominant groups. 
The association between miliary TB and tuberculous meningitis is well known. It was initially 
thought that meningitis developed only after haematogenous spread of the bacilli, but later 
studies suggest that the establishment of a sub-cortical or meningeal Rich focus leads to an 
eventual caseation and development of TBM.37 Miliary TB can therefore be considered as an 
antecedent to developing TBM, and explains why a quarter of the neutrophil predominant 
group had a miliary picture on chest radiography. 
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STRENGTHS AND LIMITATIONS 
  
To date, this is the first and largest study comparing probable and definite TBM cases in the 
paediatric population. The study spans over 30 years and include 491 cases occurring in a TB 
endemic region. All data was analysed retrospectively, but collected prospectively. The 
uniform case definition for use in clinical research was applied to all cases, making future 
comparison with further studies much easier. 
A higher volume of CSF is associated with an increased chance of bacteriological 
confirmation7 due to increased sensitivity of diagnostic tests. Unfortunately the volume of CSF 
obtained for analysis was not recorded in our database. As the study spans over 30 years, the 
more sensitive GeneXpert DNA testing was not available as a routine analysis for the majority 
of the time period. The study population also had a very low HIV prevalence, comparable to 
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Diagnostic criteria in the uniform TBM research case definition20 
 
 Diagnostic score 
Clinical criteria (Maximum category score=6) 
Symptom duration of more than 5 days 4 
Systemic symptoms suggestive of TB (1 or more of ): weight 
loss/(poor weight gain in children), night sweats or persistent cough > 
2 weeks 
2 
History of recent close contact with an individual with pulmonary TB 
or a positive TST/IGRA in a child <10 years 
2 
Focal neurological deficit (excluding cranial nerve palsies) 1 
Cranial nerve palsy 1 
CSF criteria (Maximum category score=4) 
Clear appearance 1 
Cells: 10–500 per μl 1 
Lymphocytic predominance (>50%) 1 
Protein concentration greater than 1 g/L 1 
CSF to plasma glucose ratio of less than 50% or an absolute CSF 
glucose concentration less than 2.2mmol/L 
1 
Cerebral imaging criteria (Maximum category score=6) 
Hydrocephalus 1 
Basal meningeal enhancement 2 
Tuberculoma 2 
Infarct 1 
Pre-contrast basal hyperdensity 2 
Evidence of tuberculosis elsewhere (Maximum category score=4) 
Chest X-ray suggestive of active TB (excluding miliary TB) 2 
Chest X-ray suggestive of miliary TB 4 
CT/ MRI/ US evidence for TB outside the central nervous system 2 
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AFB identified or M.tuberculosis cultured from another source i.e. 
lymph node, gastric washing, urine, blood culture 
4 
Exclusion of alternative diagnoses- An alternative diagnosis must be confirmed microbiologically, 
serologically or histopathologically 
Definite TBM = AFB seen on CSF microscopy, positive CSF M.tuberculosis culture, or positive CSF 
M.tuberculosis commercial NAAT in the setting of symptoms/signs suggestive of meningitis; or AFB seen in the 
context of histological changes consistent with TB brain or spinal cord together with suggestive symptoms/signs 
and CSF changes, or visible meningitis (on autopsy). 
Probable TBM = total score of ≥12 when neuroimaging available 
                         = total score of ≥10 when neuroimaging unavailable 
Possible TBM = total score of 6-11 when neuroimaging available 
                         = total score of 6-9 when neuroimaging unavailable 
 
TBM- tuberculous meningitis, TB- tuberculosis, TST- tuberculin skin test, IGRA- interferon gamma-release 
assay, CSF- cerebrospinal fluid, CT- computed tomography, MRI- magnetic resonance imaging, US- ultrasound, 
AFB- acid-fast bacilli,  NAAT- nucleic acid amplification test 
  





Table 1: Demographic differences in cases with definite and probable TBM 
 Definite TBM (N=98) 
n/N(%) or 95% CI 
Probable TBM 
(N=393) 
n/N(%) or 95% CI 
p-value 
Demographics    
Age in months 40.04 (34.48 to 45.60) 35.03 (32.23 to 37.83) 0.16 
Age group (in years) 
  Less than 1 
  1-2 years 
  2-5 years 












Female gender 52/98 (53) 188/392 (48) 0.37 
Ethnicity 
  African black 








(95% CI = 95% confidence interval) 
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Table 2: Difference in clinical presentation between definite and probable TBM cases. 
 Definite TBM 
n/N (%)  
Probable TBM 
n/N (%)  
p-value 
Clinical profile    
TB contact 









Stage of TBM 
  Stage I and IIa 








Duration of illness before 
admission 
  5 days and more 













44/93 (53) 131/354 (37) 0.006 
Presenting symptoms: 
  Vomiting  
  Fever 
  Malaise 
  Weight loss 
  Convulsions 
  Cough 





























  Hemiparesis 
  Meningeal irritation 
  Brainstem dysfunction  



















BCG= Bacillus Calmette-Guerin, LOC= level of consciousness 
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Table 3: Differences in results of laboratory, cerebrospinal fluid and radiological 
investigations between cases with definite and probable TBM. 
 
 Definite TBM n/N (%) 
 
Probable TBM n/N (%) p-value 
Investigations    
HIV infected 3/98 (3) 9/393 (2) 0.658 
Mantoux 










CSF investigations    
Ziehl Nielsen on CSF 







Early Hain PCR version 1 







Early Hain PCR version 2 







GeneXpert PCR on CSF 







Any PCR positive 
 
28/34 (82) 0/44 (0) <0.001 
Culture from CSF positive 
 
78/98 (80) 0/393 (0) <0.001 
Culture outside CSF positive 
 
31/98 (32)  101/393 (26) 0.236 
Microbiological confirmation 
on CSF  









Abnormality on CSF: 
  Confined to one parameter 
  Confined to two parameters 
  Confined to three parameters 
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Radiological investigations    
Chest radiograph: 
  Normal 
  Suggestive of PTB 














 Communicating hydrocephalus 
 Non- communicating 
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Table 4: Differences between neutrophil predominant and lymphocyte predominant CSF 
samples in all TBM patients 
 
 Neutrophil 
predominance in CSF  
n/N(%)  
Lymphocyte 
predominance in CSF  
n/N(%)  
p-value 
Advanced TBM stage 36/63 (57) 302/419 (72) 0.019 
HIV status 1/64 (2) 10/419 (2) 0.684 
Any PCR on CSF positive 1/5 (20) 25/68 (37) 
 
0.450 
Culture from CSF positive 12/64 (19) 66/419 (16) 0.533 
Miliary picture on CXR 15/62 (24) 47/411 (11) 0.005 
Duration of symptoms ≥ 5 days 53/60 (88) 351/412(85) 0.518 
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Table5: Comparison between study results and previous studies discerning between 
definite and probable TBM cases.  
  
 Definite TBM Probable TBM 












































































































































*Probable and possible cases included 
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